Department of Pharmacology Archives
Expanded space boosts cutting-edge research in infectious diseases and immunology
Jan. 29, 2024—The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.
Beloved VUMC colleague and acclaimed scientist David Robertson mourned
Jan. 18, 2024—David Robertson, MD, a beloved leader and mentor, and a pioneer in the clinical research of blood pressure disorders at Vanderbilt University Medical Center, died Jan. 12 at his home in Nashville. He was 76.
‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art
Jan. 16, 2024—The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.
Future of AI in medicine is bright, but rigorous validation needed
Nov. 14, 2023—Artificial intelligence has the potential to transform the practice of medicine but, like any other new tool or method, it needs to be rigorously validated before it is widely applied, cautions Vanderbilt's Dan Roden, MD.
Four named Master Innovators at Vanderbilt
Sep. 15, 2023—Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.
Grant aids drug discovery for autism, schizophrenia
Aug. 17, 2023—Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder
Study identifies key regulator of melanoma development
Jun. 29, 2023—Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity.
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jun. 5, 2023—Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.
A critical skin enzyme
May. 18, 2023—Detailed studies of the enzymatic properties of PNPLA1 support the requirement for this protein in skin barrier formation.
Pharmacology research symposium set for April 28
Apr. 20, 2023—Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year.
Roden honored for his leadership in precision medicine
Jan. 12, 2023—Vanderbilt's Dan Roden, MD, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference.
Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples
Dec. 19, 2022—BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.